ID   STP2_RAT                Reviewed;         114 AA.
AC   P11101; Q64390; Q64561; Q6AYX7;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   29-MAR-2005, sequence version 2.
DT   08-NOV-2023, entry version 134.
DE   RecName: Full=Nuclear transition protein 2;
DE            Short=TP-2;
DE            Short=TP2;
GN   Name=Tnp2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2726489; DOI=10.1093/nar/17.9.3585;
RA   Luerssen H., Maier W.-M., Hoyer-Fender S., Engel W.;
RT   "The nucleotide sequence of rat transition protein 2 (TP2) cDNA.";
RL   Nucleic Acids Res. 17:3585-3585(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Testis;
RX   PubMed=8954887; DOI=10.1006/prep.1996.0118;
RA   Meetei A.R., Rao M.R.S.;
RT   "Cloning of cDNA encoding rat spermatidal protein TP2 and expression in
RT   Escherichia coli.";
RL   Protein Expr. Purif. 8:409-415(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8720108;
RX   DOI=10.1002/(sici)1098-2795(199601)43:1<1::aid-mrd1>3.0.co;2-w;
RA   Schlueter G., Celik A.B., Obata R., Schlicker M., Hofferbert S.,
RA   Schlung A., Adham I.M., Engel W.;
RT   "Sequence analysis of the conserved protamine gene cluster shows that it
RT   contains a fourth expressed gene.";
RL   Mol. Reprod. Dev. 43:1-6(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Brown Norway; TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 89-114.
RX   PubMed=3307778; DOI=10.1016/s0006-291x(87)80140-7;
RA   Cole K.D., Kistler W.S.;
RT   "Nuclear transition protein 2 (TP2) of mammalian spermatids has a very
RT   basic carboxyl terminal domain.";
RL   Biochem. Biophys. Res. Commun. 147:437-442(1987).
RN   [6]
RP   ZINC-BINDING.
RX   PubMed=1930189; DOI=10.1016/0006-291x(91)91741-t;
RA   Baskaran R., Rao M.R.S.;
RT   "Mammalian spermatid specific protein, TP2, is a zinc metalloprotein with
RT   two finger motifs.";
RL   Biochem. Biophys. Res. Commun. 179:1491-1499(1991).
RN   [7]
RP   ZINC-BINDING.
RX   PubMed=8076694; DOI=10.1016/0014-5793(94)00799-3;
RA   Kundu T.K., Rao M.R.S.;
RT   "Characterization of the zinc-metalloprotein nature of rat spermatidal
RT   protein TP2.";
RL   FEBS Lett. 351:6-10(1994).
RN   [8]
RP   MUTAGENESIS, AND SUBCELLULAR LOCATION.
RX   PubMed=10961985; DOI=10.1074/jbc.m002734200;
RA   Meetei A.R., Ullas K.S., Rao M.R.S.;
RT   "Identification of two novel zinc finger modules and nuclear localization
RT   signal in rat spermatidal protein TP2 by site-directed mutagenesis.";
RL   J. Biol. Chem. 275:38500-38507(2000).
RN   [9]
RP   FUNCTION, TISSUE SPECIFICITY, PHOSPHORYLATION AT THR-101 AND SER-109, AND
RP   MUTAGENESIS OF SER-68; SER-90; THR-101; SER-108 AND SER-109.
RX   PubMed=11772016; DOI=10.1021/bi0117652;
RA   Meetei A.R., Ullas K.S., Vasupradha V., Rao M.R.S.;
RT   "Involvement of protein kinase A in the phosphorylation of spermatidal
RT   protein TP2 and its effect on DNA condensation.";
RL   Biochemistry 41:185-195(2002).
RN   [10]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=14514679; DOI=10.1074/jbc.m308365200;
RA   Ullas K.S., Rao M.R.S.;
RT   "Phosphorylation of rat spermatidal protein TP2 by sperm-specific protein
RT   kinase A and modulation of its transport into the haploid nucleus.";
RL   J. Biol. Chem. 278:52673-52680(2003).
RN   [11]
RP   SUBCELLULAR LOCATION.
RX   PubMed=17682055; DOI=10.1128/mcb.00519-07;
RA   Pradeepa M.M., Manjunatha S., Sathish V., Agrawal S., Rao M.R.;
RT   "Involvement of importin-4 in the transport of transition protein 2 into
RT   the spermatid nucleus.";
RL   Mol. Cell. Biol. 28:4331-4341(2008).
CC   -!- FUNCTION: Plays a key role in the replacement of histones to protamine
CC       in the elongating spermatids of mammals (PubMed:11772016). In
CC       condensing spermatids, loaded onto the nucleosomes, where it promotes
CC       the recruitment and processing of protamines, which are responsible for
CC       histone eviction (By similarity). {ECO:0000250|UniProtKB:P11378,
CC       ECO:0000269|PubMed:11772016}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10961985,
CC       ECO:0000269|PubMed:14514679, ECO:0000269|PubMed:17682055}. Nucleus,
CC       nucleolus {ECO:0000269|PubMed:10961985, ECO:0000269|PubMed:14514679}.
CC       Chromosome {ECO:0000269|PubMed:14514679}. Note=Loaded onto the
CC       nucleosomes of condensing spermatids (By similarity). Nuclear import is
CC       mediated by IPO4 (PubMed:17682055). Nucleolar localization requires the
CC       protein to be phosphorylated (PubMed:14514679).
CC       {ECO:0000250|UniProtKB:P11378, ECO:0000269|PubMed:14514679,
CC       ECO:0000269|PubMed:17682055}.
CC   -!- TISSUE SPECIFICITY: Testis. {ECO:0000269|PubMed:11772016,
CC       ECO:0000269|PubMed:14514679}.
CC   -!- DEVELOPMENTAL STAGE: Expressed during stages 12-15 of spermiogenesis.
CC       {ECO:0000269|PubMed:14514679}.
CC   -!- SIMILARITY: Belongs to the nuclear transition protein 2 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X14776; CAA32882.1; -; mRNA.
DR   EMBL; U52958; AAB02693.1; -; mRNA.
DR   EMBL; Z46939; CAA87064.1; -; Genomic_DNA.
DR   EMBL; BC078849; AAH78849.1; -; mRNA.
DR   PIR; S04094; S04094.
DR   PIR; S57667; S57667.
DR   RefSeq; NP_058753.2; NM_017057.2.
DR   AlphaFoldDB; P11101; -.
DR   BioGRID; 246958; 3.
DR   STRING; 10116.ENSRNOP00000003455; -.
DR   iPTMnet; P11101; -.
DR   PhosphoSitePlus; P11101; -.
DR   PaxDb; 10116-ENSRNOP00000003455; -.
DR   GeneID; 24840; -.
DR   KEGG; rno:24840; -.
DR   UCSC; RGD:3885; rat.
DR   AGR; RGD:3885; -.
DR   CTD; 7142; -.
DR   RGD; 3885; Tnp2.
DR   eggNOG; KOG4566; Eukaryota.
DR   InParanoid; P11101; -.
DR   PRO; PR:P11101; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0001673; C:male germ cell nucleus; ISO:RGD.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0000786; C:nucleosome; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0008270; F:zinc ion binding; IDA:RGD.
DR   GO; GO:0007340; P:acrosome reaction; ISO:RGD.
DR   GO; GO:0007339; P:binding of sperm to zona pellucida; ISO:RGD.
DR   GO; GO:0030317; P:flagellated sperm motility; ISO:RGD.
DR   GO; GO:0007341; P:penetration of zona pellucida; ISO:RGD.
DR   GO; GO:0010954; P:positive regulation of protein processing; ISS:UniProtKB.
DR   GO; GO:0035092; P:sperm DNA condensation; ISS:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; ISO:RGD.
DR   InterPro; IPR000678; TP2.
DR   PANTHER; PTHR17488; NUCLEAR TRANSITION PROTEIN 2; 1.
DR   PANTHER; PTHR17488:SF0; NUCLEAR TRANSITION PROTEIN 2; 1.
DR   Pfam; PF01254; TP2; 2.
DR   PROSITE; PS00970; TP2_1; 1.
DR   PROSITE; PS00971; TP2_2; 1.
PE   1: Evidence at protein level;
KW   Chromosome; Developmental protein; Differentiation;
KW   Direct protein sequencing; DNA-binding; Metal-binding; Nucleosome core;
KW   Nucleus; Phosphoprotein; Reference proteome; Spermatogenesis; Zinc.
FT   CHAIN           1..114
FT                   /note="Nuclear transition protein 2"
FT                   /id="PRO_0000191433"
FT   REGION          1..114
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           87..95
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000269|PubMed:10961985,
FT                   ECO:0000269|PubMed:17682055"
FT   COMPBIAS        1..47
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        86..114
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         12
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:1930189,
FT                   ECO:0000269|PubMed:8076694"
FT   BINDING         14
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:1930189,
FT                   ECO:0000269|PubMed:8076694"
FT   BINDING         16
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:1930189,
FT                   ECO:0000269|PubMed:8076694"
FT   BINDING         24
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:1930189,
FT                   ECO:0000269|PubMed:8076694"
FT   BINDING         29
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:1930189,
FT                   ECO:0000269|PubMed:8076694"
FT   BINDING         31
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:1930189,
FT                   ECO:0000269|PubMed:8076694"
FT   BINDING         35
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:1930189,
FT                   ECO:0000269|PubMed:8076694"
FT   BINDING         38
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:1930189,
FT                   ECO:0000269|PubMed:8076694"
FT   MOD_RES         101
FT                   /note="Phosphothreonine; by PKA"
FT                   /evidence="ECO:0000269|PubMed:11772016"
FT   MOD_RES         109
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000269|PubMed:11772016"
FT   MUTAGEN         12
FT                   /note="H->Q: 50% loss of zinc binding; when associated with
FT                   Q-14; Q-16 and Q-24."
FT                   /evidence="ECO:0000269|PubMed:10961985"
FT   MUTAGEN         14
FT                   /note="H->Q: 50% loss of zinc binding; when associated with
FT                   Q-12; Q-16 and Q-24."
FT                   /evidence="ECO:0000269|PubMed:10961985"
FT   MUTAGEN         16
FT                   /note="H->Q: 50% loss of zinc binding; when associated with
FT                   Q-12; Q-14 and Q-24."
FT                   /evidence="ECO:0000269|PubMed:10961985"
FT   MUTAGEN         24
FT                   /note="H->Q: 50% loss of zinc binding; when associated with
FT                   Q-12; Q-14 and Q-16."
FT                   /evidence="ECO:0000269|PubMed:10961985"
FT   MUTAGEN         29
FT                   /note="C->A: 50% loss of zinc binding and loss of nucleolar
FT                   localization; when associated with A-31; A-35 and A-38."
FT                   /evidence="ECO:0000269|PubMed:10961985"
FT   MUTAGEN         31
FT                   /note="C->A: 50% loss of zinc binding and loss of nucleolar
FT                   localization; when associated with A-29; A-35 and A-38."
FT                   /evidence="ECO:0000269|PubMed:10961985"
FT   MUTAGEN         35
FT                   /note="C->A: 50% loss of zinc binding and loss of nucleolar
FT                   localization; when associated with A-29; A-31 and A-38."
FT                   /evidence="ECO:0000269|PubMed:10961985"
FT   MUTAGEN         38
FT                   /note="C->A: 50% loss of zinc binding and loss of nucleolar
FT                   localization; when associated with A-29; A-31 and A-35."
FT                   /evidence="ECO:0000269|PubMed:10961985"
FT   MUTAGEN         68
FT                   /note="S->A: No effect on phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:11772016"
FT   MUTAGEN         90
FT                   /note="S->A: No effect on phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:11772016"
FT   MUTAGEN         101
FT                   /note="T->A: Slight decrease in phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:11772016"
FT   MUTAGEN         108
FT                   /note="S->A: No effect on phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:11772016"
FT   MUTAGEN         109
FT                   /note="S->A: Large decrease in phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:11772016"
FT   CONFLICT        1..8
FT                   /note="MDTKMQSL -> MGGHTRRGRA (in Ref. 1; CAA32882)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        52
FT                   /note="P -> S (in Ref. 4; AAH78849)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        109
FT                   /note="S -> SV (in Ref. 3; CAA87064)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   114 AA;  12848 MW;  E9EFAF3BE3FC1A7C CRC64;
     MDTKMQSLPT THPHPHSSSR PQSHTNNQCA CSHHCRSCSQ AGHPSSSSSP SPGPPTKHPK
     TPMHSRYSPS RPSHRGSCPK NRKTLEGKVS KRKAVRRRKR THRAKRRSSG RRYK
//
